Table 3 The cochrane collaboration’s tool for assessing risk of bias in randomized trials.

From: Immunosuppressive therapy in patients with biopsy-proven inflammatory myocardial disease: a systematic review and meta-analysis

Study

Randomisation process

Deviations from the intended interventions

Missing outcome data

Measurement of the outcome

Selection of the reported result

Overall

Hazebroek et al.13

( +)

( +)

( +)

( +)

( +)

( +)

Wojnicz et al.15

(!)

( +)

( +)

(!)

(!)

(!)

Frustaci et al.16

( +)

( +)

( +)

( +)

( +)

( +)

Schultheiss et al.17

( +)

( +)

( +)

( +)

( +)

( +)

Parrillo et al.18

(!)

(!)

(–)

( +)

(!)

(–)

Poloczkova et al.14

(!)

(!)

( +)

(!)

( +)

(!)

Mason et al.19

(!)

( +)

( +)

(!)

(!)

(!)

( +) Low risk of bias; (–) high risk of bias; (!) some concerns

  1. The risk of bias 2 (RoB 2) tool assesses the risk of bias in randomized trials, assessing (1) Randomization Process, (2) Deviations from the intended interventions, (3) Missing outcome data, (4) Measurement of the outcome, (5) Selection of the reported result, (6) Overall risk of bias.